Premium
Briefly Noted
Publication year - 2019
Publication title -
alcoholism and drug abuse weekly
Language(s) - English
Resource type - Journals
eISSN - 1556-7591
pISSN - 1042-1394
DOI - 10.1002/adaw.32392
Subject(s) - miami , reimbursement , substance abuse , value (mathematics) , miller , psychological intervention , payment , health care , grossman , medicine , library science , sociology , family medicine , gerontology , psychology , political science , psychiatry , law , business , environmental science , machine learning , computer science , soil science , ecology , finance , keynesian economics , economics , biology
A conference focusing on “value” — money well spent — in substance use disorder (SUD) treatment featured payment and reimbursement, and, in a refreshing twist, researchers instead of administrators and payers. Led by CHERISH (the Center for Health Economics of Treatment Interventions for Substance Use Disorder, HCV, and HIV, a collaboration of Cornell Weill Medicine, Boston Medical Center, the University of Miami Miller School of Medicine and the University of Pennsylvania, funded by the National Institute on Drug Abuse), the conference, held May 31 at the Leonard David Institute of Health at the University of Pennsylvania, featured speakers from the SUD treatment community who espouse medications. Topics and speakers included: ways to eliminate low‐value care (Joshua Sharfstein, M.D.), what value means (Colleen Barry, Ph.D., Brendan Saloner, Ph.D., and overcoming barriers to effective treatment (Michael Botticelli, Alexis Horan). It did give attendees the opportunity to network and interact directly, as researchers and policymakers, on how to overcome barriers to SUD treatment in communities. The bottom line: What works should be covered; what doesn't shouldn't.